Versant Venture Capital VI, L.P.

Holdings History for Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST)

Symbol: TPST on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 162,972 shares
Security Ownership %: 3.7%

Versant Vantage II, L.P. ownership in Tempest Therapeutics, Inc. Common Stock, par value $0.001 per share (TPST)

13 Aug 2025 - Versant Vantage II, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 162,972 shares of Tempest Therapeutics, Inc. Common Stock, par value $0.001 per share (TPST). This represents 3.7% ownership of the company. In their previous filing dated 11 Feb 2025, Versant Venture Capital VI, L.P. had reported owning 2,118,644 shares, indicating a decrease of +92%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Versant Vantage II, L.P.	3.7%	-22%	$1,108,210	162,972	-1,955,672	-92%	$6.80	13D/A	11 Aug 2025	13 Aug 2025, 19:14
Versant Vantage II, L.P.	4.8%		$1,080,508	2,118,644			$0.51	13D/A	12 Nov 2024	11 Feb 2025, 17:58